Introduction: Individual centres in the UK often report good survival rates for patients with neuroendocrine tumours (NETs), however national survival data has not been available.
Aim(s): To calculate NET survival in England using Public Health England (PHE) National Cancer Registration and Analysis Service (NCRAS) population-based registry data.
Materials and methods: The Kaplan-Meier method was used to analyse survival in 12,844 patients diagnosed with NETs in England between 2013 and 2015.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Tracey Genus
, Bouvier C
, Wong K
, Srirajaskanthan R
, Rous B
, Talbot D
, Valle J
, Khan M S
, Pearce N
, Elshafie M
, Reed N
, Ramage J
To read results and conclusion, please login ...
Further abstracts you may be interested in